Shanghai Runda Med Tech Co (603108) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Runda Med Tech Co (603108) has a cash flow conversion efficiency ratio of 0.028x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥144.38 Million ≈ $21.13 Million USD) by net assets (CN¥5.15 Billion ≈ $752.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Runda Med Tech Co - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Shanghai Runda Med Tech Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603108 total liabilities for a breakdown of total debt and financial obligations.
Shanghai Runda Med Tech Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Runda Med Tech Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blacksky Technology Inc
NYSE:BKSY
|
-0.098x |
|
Ningbo Kangqiang Electronics Co Ltd
SHE:002119
|
0.001x |
|
Inrom Construction Industries Ltd
TA:INRM
|
0.024x |
|
Kestra Medical Technologies, Ltd. Common Stock
NASDAQ:KMTS
|
-0.112x |
|
Fras-le S.A
SA:FRAS3
|
0.130x |
|
Godrej Agrovet Limited
NSE:GODREJAGRO
|
0.170x |
|
Teladoc Inc
NYSE:TDOC
|
0.071x |
|
China Harzone Industry Corp Ltd
SHE:300527
|
0.010x |
Annual Cash Flow Conversion Efficiency for Shanghai Runda Med Tech Co (2014–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Runda Med Tech Co from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see 603108 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.60 Billion ≈ $820.06 Million |
CN¥646.95 Million ≈ $94.67 Million |
0.115x | -13.83% |
| 2023-12-31 | CN¥5.45 Billion ≈ $797.10 Million |
CN¥729.72 Million ≈ $106.78 Million |
0.134x | +256.49% |
| 2022-12-31 | CN¥5.01 Billion ≈ $733.10 Million |
CN¥-428.86 Million ≈ $-62.76 Million |
-0.086x | -201.31% |
| 2021-12-31 | CN¥4.39 Billion ≈ $642.69 Million |
CN¥371.11 Million ≈ $54.31 Million |
0.084x | +6.59% |
| 2020-12-31 | CN¥4.08 Billion ≈ $597.07 Million |
CN¥323.44 Million ≈ $47.33 Million |
0.079x | +13.00% |
| 2019-12-31 | CN¥3.52 Billion ≈ $514.56 Million |
CN¥246.68 Million ≈ $36.10 Million |
0.070x | -59.24% |
| 2018-12-31 | CN¥3.13 Billion ≈ $458.14 Million |
CN¥538.90 Million ≈ $78.86 Million |
0.172x | +638.52% |
| 2017-12-31 | CN¥2.75 Billion ≈ $402.20 Million |
CN¥-87.85 Million ≈ $-12.86 Million |
-0.032x | +43.39% |
| 2016-12-31 | CN¥2.22 Billion ≈ $325.17 Million |
CN¥-125.47 Million ≈ $-18.36 Million |
-0.056x | +76.87% |
| 2015-12-31 | CN¥928.55 Million ≈ $135.88 Million |
CN¥-226.69 Million ≈ $-33.17 Million |
-0.244x | -421.52% |
| 2014-12-31 | CN¥475.63 Million ≈ $69.60 Million |
CN¥36.11 Million ≈ $5.28 Million |
0.076x | -- |
About Shanghai Runda Med Tech Co
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technica… Read more